ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1911

Decade

Year

Issue

October 2021, Vol 175, No. 10, Pages 990-1088

Viewpoint

Dismantling Structural Discrimination in Global Health

Abstract Full Text
JAMA Pediatr. 2021;175(10):993-994. doi:10.1001/jamapediatrics.2021.1065

This Viewpoint describes steps to reduce structural racism and other forms of discrimination in global health, particularly within the United Nations network.

COVID-19 Vaccination of Minors Without Parental Consent: Respecting Emerging Autonomy and Advancing Public Health

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):995-996. doi:10.1001/jamapediatrics.2021.1855

This Viewpoint discusses allowing minors to consent and receive the COVID-19 vaccine without parental authorization.

Interoperability and Information-Blocking Rules: Implications for Pediatric and Adolescent Health Care Professionals

Abstract Full Text
JAMA Pediatr. 2021;175(10):997-998. doi:10.1001/jamapediatrics.2021.2077

This Viewpoint describes evolving legislation and technology needs for ensuring appropriate medical information is shared with or blocked from pediatric patients and their proxies.

Youth Insured By Medicaid With Restrictive Eating Disorders—Underrecognized and Underresourced

Abstract Full Text
JAMA Pediatr. 2021;175(10):999-1000. doi:10.1001/jamapediatrics.2021.2081

This Viewpoint describes the dearth of care available to individuals with eating disorders who rely on Medicaid benefits and describes methods to ensure equitable treatment access irrespective of payer.

Editorial

Advances in Understanding the Association Between Pediatric Traumatic Brain Injury and Attention-Deficit/Hyperactivity Disorder

Abstract Full Text
JAMA Pediatr. 2021;175(10):1001-1003. doi:10.1001/jamapediatrics.2021.2038

Evolving Respiratory Care of the Preterm Infant

Abstract Full Text
JAMA Pediatr. 2021;175(10):1004-1005. doi:10.1001/jamapediatrics.2021.1918

The Pediatric Subspecialty Workforce Is More Complex Than Meets the Eye

Abstract Full Text
JAMA Pediatr. 2021;175(10):1006-1008. doi:10.1001/jamapediatrics.2021.1909

Implications of SARS-CoV-2 Viral Load in Children: Getting Back to School and Normal

Abstract Full Text
free access online only
JAMA Pediatr. 2021;175(10):e212022. doi:10.1001/jamapediatrics.2021.2022
Original Investigation

Association of Attention-Deficit/Hyperactivity Disorder Diagnoses With Pediatric Traumatic Brain Injury: A Meta-analysis

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1009-1016. doi:10.1001/jamapediatrics.2021.2033

This meta-analysis examines the rates of attention-deficit/hyperactivity disorder reported in studies of children who have experienced traumatic brain injury.

Changes in Use of Respiratory Support for Preterm Infants in the US, 2008-2018

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1017-1024. doi:10.1001/jamapediatrics.2021.1921

This cohort study examines the changes in the use of mechanical ventilation in preterm infants during the past decade.

Association of High Screen-Time Use With School-age Cognitive, Executive Function, and Behavior Outcomes in Extremely Preterm Children

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1025-1034. doi:10.1001/jamapediatrics.2021.2041

This cohort study assesses the association of screen time with cognition, language, executive function, and behavior in children at ages 6 to 7 years who were born extremely prematurely.

Temporal Trends in Neurodevelopmental Outcomes to 2 Years After Extremely Preterm Birth

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1035-1042. doi:10.1001/jamapediatrics.2021.2052

This cohort study compares changes in neurodevelopmental outcomes at 2 years in extremely preterm children born between 1991 and 2017.

Temporal Trends in Opioid Prescribing Practices in Children, Adolescents, and Younger Adults in the US From 2006 to 2018

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1043-1052. doi:10.1001/jamapediatrics.2021.1832

This cross-sectional study examines the rates of opioid prescribing and duration of those prescriptions in children, adolescents, and younger adults from 2006 to 2018.

Association of Lifetime Earning Potential and Workforce Distribution Among Pediatric Subspecialists

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1053-1059. doi:10.1001/jamapediatrics.2021.1912

This cross-sectional study evaluates the association between lifetime earning potential and workforce distribution and the potential role of a pediatric subspecialist–specific loan repayment program in workforce expansion.

Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting

Abstract Full Text
free access online only
JAMA Pediatr. 2021;175(10):e212025. doi:10.1001/jamapediatrics.2021.2025

This cross-sectional study characterizes the symptoms of pediatric COVID-19 in the community and analyzes the association of symptoms and SARS-CoV-2 RNA levels, as approximated by cycle threshold values, in children and adults.

Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children: A Systematic Review and Meta-analysis

Abstract Full Text
free access online only
JAMA Pediatr. 2021;175(10):e212328. doi:10.1001/jamapediatrics.2021.2328

This systematic review and meta-analysis assesses the prevalence of Clostridioides difficile detection among asymptomatic children.

Review

Low von Willebrand Factor in Children and Adolescents: A Review

Abstract Full Text
JAMA Pediatr. 2021;175(10):1060-1067. doi:10.1001/jamapediatrics.2021.2186

This narrative review of low von Willebrand factor in children and adolescents summarizes the observations of several studies on low von Willebrand factor and bleeding and available diagnostic modalities and treatment options.

JAMA Pediatrics Patient Page

What Parents Need to Know About Childhood Oral Health

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1088. doi:10.1001/jamapediatrics.2021.1482

This Patient Page describes what childhood caries are and how to prevent them.

Research Letter

Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk

Abstract Full Text
open access
JAMA Pediatr. 2021;175(10):1069-1071. doi:10.1001/jamapediatrics.2021.1929

This cohort study analyzes milk samples from lactating mothers to determine if COVID-19 vaccine–related messenger RNA was detectable in human milk after vaccination.

Low-Density Lipoprotein Cholesterol Trajectories and Prevalence of High Low-Density Lipoprotein Cholesterol Consistent With Heterozygous Familial Hypercholesterolemia in US Children

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1071-1074. doi:10.1001/jamapediatrics.2021.2046

This cohort study aims to characterize age-related longitudinal low-density lipoprotein trajectories among US children.

Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey–Teen, 2008 to 2019

Abstract Full Text
open access
JAMA Pediatr. 2021;175(10):1074-1076. doi:10.1001/jamapediatrics.2021.1585

This secondary analysis assesses safety concerns and adverse effects as reported reasons for HPV vaccine refusal.

Summary of Literature on Pediatric Real-world Evidence and Effectiveness

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):1077-1079. doi:10.1001/jamapediatrics.2021.2149

This cross-sectional study investigates the use of real-world data and real-world evidence in informing medicine efficacy in pediatric literature.

Comment & Response

Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids?

Abstract Full Text
JAMA Pediatr. 2021;175(10):1079. doi:10.1001/jamapediatrics.2021.1858

Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids?—Reply

Abstract Full Text
JAMA Pediatr. 2021;175(10):1079-1080. doi:10.1001/jamapediatrics.2021.1861

Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids?—Reply

Abstract Full Text
JAMA Pediatr. 2021;175(10):1080-1081. doi:10.1001/jamapediatrics.2021.1864

Additional Counseling Support for Mothers With Gestational Hypertensive Disorders Regarding Neurodevelopmental Outcomes in Their Children

Abstract Full Text
JAMA Pediatr. 2021;175(10):1081-1082. doi:10.1001/jamapediatrics.2021.2074

Additional Counseling Support for Mothers With Gestational Hypertensive Disorders Regarding Neurodevelopmental Outcomes in Their Children—Reply

Abstract Full Text
JAMA Pediatr. 2021;175(10):1082. doi:10.1001/jamapediatrics.2021.2071
JAMA Pediatrics Masthead

JAMA Pediatrics

Abstract Full Text
free access
JAMA Pediatr. 2021;175(10):990. doi:10.1001/jamapediatrics.2020.4201
×